Welcome to our dedicated page for Delphx Cap Mkts news (Ticker: DPXCF), a resource for investors and traders seeking the latest updates and insights on Delphx Cap Mkts stock.
DelphX Capital Markets Inc. (DPXCF) provides advanced structured products for fixed income market participants, specializing in credit risk mitigation through instruments like collateralized put options and reference notes. This page serves as the definitive source for official company announcements and market-relevant updates.
Access real-time press releases covering strategic partnerships, product innovations, and financial performance. Investors will find critical updates on securities offerings, regulatory developments, and operational milestones that impact credit risk management strategies.
Our curated news collection enables institutional clients and analysts to track DelphX's progress in developing collateralized solutions while monitoring key initiatives through Quantem LLC subsidiary. Content spans earnings disclosures, technology implementations, and market expansion efforts.
Bookmark this resource to maintain awareness of DelphX's evolving role in creating transparent risk transfer mechanisms for fixed income dealers. Regular updates ensure you stay informed about developments affecting credit rating security products and related financial instruments.
DelphX Capital Markets (OTCQB: DPXCF) provided an update on its Quantem Crypto Securities (QCS) program. The company's fully collateralized QCS offering is currently under evaluation by multiple digital asset treasuries and hedge funds for portfolio inclusion.
The company will attend the Bitcoin Treasuries Conference in New York to advance discussions with potential first adopters and partners, expecting initial alignments by month-end. Additionally, DelphX is exploring the establishment of its own digital asset treasury that would incorporate QCS as a direct downside hedge.
QCS is positioned as one of the few Wall Street-originated structured products for decentralized markets, offering institutional investors downside protection against cryptocurrency price declines while eliminating counterparty risk.
DelphX Capital Markets (OTCQB: DPXCF) has completed an additional issuance of 1,000,000 units at C$0.05 per unit, raising C$50,000 in a non-brokered private placement. This brings the total placement to 6,000,000 units for C$300,000. Each unit includes one common share and one warrant exercisable at C$0.08 for two years.
Insiders participated by subscribing for 1,000,000 units. The company also granted 1,800,000 stock options with a two-year maturity, exercisable at C$0.08 per share. The private placement proceeds will be used for general corporate purposes.
DelphX Capital Markets (OTCQB: DPXCF) has completed a non-brokered private placement offering of 5,000,000 units at C$0.05 per unit, raising total gross proceeds of C$250,000. Each unit comprises one common share and one warrant, with warrants exercisable at C$0.08 per share for two years.
Company insiders participated in the offering by subscribing for 200,000 units. The transaction qualified as a "related party transaction" but was exempt from formal valuation and minority approval requirements. The securities will be subject to a four-month plus one day hold period, and proceeds will be used for general corporate purposes.
DelphX Capital Markets (OTCQB: DPXCF) is seeking TSX Venture Exchange approval to extend the exercise period of two sets of share purchase warrants. The company aims to extend 4,825,715 warrants exercisable at $0.30 per share to August 25, 2026, and 2,825,000 warrants exercisable at $0.15 per share to August 30, 2026.
Of these warrants, 1,929,286 are held by related parties, constituting a related party transaction. The transaction qualifies for exemption from formal valuation and minority approval requirements as the warrants' fair market value is below 25% of DelphX's market capitalization.
DelphX Capital Markets (OTCQB: DPXCF) provided a midsummer business update highlighting three key revenue verticals. The company is expanding its broker-dealer operations to include marketing private placements for growth companies across North America, with two engagements already secured. DelphX is also developing a new crypto-focused product called Quantem Crypto Security (QCS), expected to launch in late August or early September 2025, aimed at helping institutional buyers hedge crypto holdings with reduced counterparty risks.
The company continues development of its Credit Rating Securities (CRS) product while large insurers evaluate it. The new private placement business is expected to generate fee-based revenue to support operations while CRS progresses to market.
DelphX Capital Markets (OTCQB: DPXCF), a structured products developer for the fixed income market, has completed a non-brokered private placement. The company raised C$152,400 through the issuance of 2,540,000 units at C$0.06 per unit.
Each unit comprises one common share and one warrant, with warrants exercisable at C$0.08 per share for a two-year period. The offering is subject to TSX Venture Exchange final acceptance, with securities having a four-month plus one-day hold period. Proceeds will support general corporate purposes.
DelphX Capital Markets (OTCQB: DPXCF) has announced a non-brokered private placement offering of 2,151,000 units at C$0.07 per unit, aiming to raise gross proceeds of C$150,570. Each unit comprises one common share and one purchase warrant, with warrants exercisable at $0.20 per share for five years from issuance.
The company will pay cash finder's fees and issue finders' warrants to eligible finders, exercisable at $0.20 for five years. The offering is subject to TSX Venture Exchange approval and includes a four-month plus one-day hold period. Company insiders may participate in the offering, with proceeds intended for general corporate purposes.
DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), a company focused on developing structured products for the fixed income market, has announced a new stock options grant. The Board of Directors has approved the issuance of 576,667 stock options to eligible participants under its stock option plan.
The granted options come with a two-year maturity period and can be exercised at a price of $0.10 per common share.